Patent · US Active

Process for preparing SGLT2 inhibitors and intermediates thereof

US9834533B2 · kind B2 · utility

2Cited by
2References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 10, 2017
Grant dateDec 5, 2017
Priority date—
Expiry dateFeb 10, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D407/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides processes for preparing SGLT2 inhibitors, such as dapagliflozin and empagliflozin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.